IP Verse

United Therapeutics Corp competitive analysis

Latest patents of United Therapeutics Corp opposed by its competitors

Explore United Therapeutics Corp's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Mar 12, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP3172220
Dec 27, 2023Method For Purifying Antibodies2
EP2711024
Mar 6, 2019Buffer Solutions Having Selective Bactericidal Activity Against Gram Negative Bacteria And Methods Of Using Same2

Latest PTAB cases involving United Therapeutics Corp

Discover the latest PTAB cases involving United Therapeutics Corp, highlighting their recent legal challenges and patent disputes.

Last updated on: Mar 12, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving United Therapeutics Corp

IPR2025-01139Jun 10, 2025UNITED THERAPEUTICSACTELION PHARMACEUTICALSDiscretionary Denial
IPR2021-00406Jan 7, 2021LIQUIDIAUNITED THERAPEUTICSFinal Written Decision
IPR2020-00769Mar 30, 2020LIQUIDIAUNITED THERAPEUTICSInstitution Denied
IPR2020-00770Mar 30, 2020LIQUIDIA TECHNOLGIESUNITED THERAPEUTICSFinal Written Decision
IPR2017-01621Jun 21, 2017WATSON LABORATORIESUNITED THERAPEUTICSTerminated-Settled
IPR2017-01622Jun 21, 2017WATSON LABORATORIESUNITED THERAPEUTICSTerminated-Settled
IPR2016-00006Oct 2, 2015STEADYMEDUNITED THERAPEUTICSFinal Written Decision

Peer Comparison New

IP litigation analysis comparing United Therapeutics Corp with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Mar 12, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
UNITED THERAPEUTICS - 416
GENERICS UK216 - - -
LIQUIDIA - - 2 -
WATSON LABORATORIES - - 2 -